Aug. 26 at 8:27 PM
$PAHC Phibro Animal Health reports Q4 adjusted EPS 85c, consensus 73c
Reports Q4 revenue
$396.7M, consensus
$378.33M. "Fiscal 2026 was a year of meaningful progress for Phibro," said Dani Bendheim, President and Chief Executive Officer of Phibro Animal Health Corporation. "We delivered record net sales of
$1.5 billion, increased Adjusted EBITDA by 39% to
$255 million, expanded margins, and continued to improve our business. These results reflect the dedication of our employees around the world and the value of our diversified portfolio."
